4 ms·
From the abstract this study finds that taking Asprin from 50-65 should yield a 4% reduction in deaths over a 20 year period. It specifically says that at least
by learc83 12y ago
From the abstract this study finds that taking Asprin from 50-65 should yield a 4% reduction in deaths over a 20 year period. It specifically says that at least for 50-65 year olds, the benefits outweigh the risks of bleeding.
- XFrequentist 12y agoSweet! I haven't read the article (or even the abstract) yet, glad to hear that they were able to nail down a recommendation. Thanks for letting me know.
- tempestn 12y agoYou wrote a comment refuting the article's headline before looking at the article itself?
- mapleoin 12y agoWelcome to the internet.
- XFrequentist 12y agoI meant that I hadn't yet read the original scientific publication [1] (I have now), not that I hadn't read the Guardian piece. I also wouldn't agree that I was refuting the headline, I was just giving background. The scientific paper is very clear that this is an advance along precisely the lines I said were needed (ie defining a group for whom benefits outweigh harms), but the Guardian piece makes it sound like Aspirin's chemopreventive effect had just been discovered whole cloth. [1] http://annonc.oxfordjournals.org/content/early/2014/07/30/annonc.mdu225.full http://annonc.oxfordjournals.org/content/early/2014/07/30/an...
- gwern 12y agoYou know, all of these meta-analyses for years have been turning in estimates of lowering all-cause mortality. It's not new.